Spanish seed breeder Fitó and Dutch crop-genomics company Hudson River Biotechnology have announced a long-term research partnership, initially focused on developing new traits within Fitó’s existing tomato breeding lines. The collaboration was presented at Fruit Attraction 2026 in Madrid, as reported by Infoagro on 9 October, and is also described in the partners’ announcement circulated via SeedQuest.
The agreement combines Fitó’s germplasm, commercial breeding experience and grower-market knowledge with Hudson River’s genome-editing and plant-regeneration capabilities. The partners describe it as a continuing R&D collaboration, not a finished product launch or a claim that modified tomato varieties are already available to growers.
Research starts with Fitó’s tomato lines
The partners plan to use Hudson River’s BioMaas platform to generate genetic variation within Fitó’s own breeding material. Priorities include resistance to plant diseases and pests, alongside post-harvest shelf life and nutritional characteristics. They expect their research teams to jointly select traits, assess breeding opportunities and adjust projects as evidence emerges.
The stated aim is to move prospective genetic improvements into material that a commercial breeding programme can use. That is a more limited stage than introducing a new cultivar to growers: a successful laboratory edit must still be integrated into breeding, evaluated for agronomic performance and developed into a marketable variety.
Implications for professional tomato production
For greenhouse tomato growers and seed buyers, the relevance lies in the possible future combination of established commercial breeding lines with new traits. Disease resistance may influence crop-protection requirements, while shelf life is a consideration across harvesting, packing and distribution. The companies have described these as research objectives; they have not published comparative field-trial results, named a jointly developed commercial variety or established when growers could buy resulting seed.
The collaboration also reflects the industry’s interest in preparing plant-breeding programmes for evolving European rules around new genomic techniques. However, the announcement does not constitute a regulatory approval for any specific edited tomato, nor does it establish a release date. No deal value, project budget or exclusivity terms have been publicly quantified in the announcement.
Key takeaways
- Fitó and Hudson River Biotechnology announced a long-term crop-breeding R&D partnership in October 2026.
- Initial work uses tomato breeding lines and Hudson River’s BioMaas genome-editing and regeneration capabilities.
- Resistance, shelf life and nutritional traits are research goals, not commercially validated or released varieties.
Featured image: tomato seedlings (illustrative photograph; not material produced through this collaboration). Dwight Sipler / Wikimedia Commons, CC BY 2.0.
